Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Marta López González, Dinja Oosterhoff, Jelle J. Lindenberg, Ioanna Milenova, Sinead M. Lougheed, Tania Martiáñez, Henk Dekker, Dafne Carolina Alves Quixabeira, Basav Hangalapura, Jos Joore, Sander R. Piersma, Victor Cervera-Carrascon, Joao Manuel Santos, Rik J. Scheper, Henk M.W. Verheul, Connie R. Jiménez, Rieneke Van De Ven, Akseli Hemminki, Victor W. Van Beusechem & Tanja D. De Gruijl. (2019) Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression. OncoImmunology 8:10.
Read now
Read now
Tanja D de Gruijl, Axel B Janssen & Victor W van Beusechem. (2015) Arming oncolytic viruses to leverage antitumor immunity. Expert Opinion on Biological Therapy 15:7, pages 959-971.
Read now
Read now
A Marijne Heeren, Gemma G Kenter, Ekaterina S Jordanova & Tanja D de Gruijl. (2015) CD14+ macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead?. OncoImmunology 4:6.
Read now
Read now
Lisa K Spary, Josephine Salimu, Jason P Webber, Aled Clayton, Malcolm D Mason & Zsuzsanna Tabi. (2014) Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14+ PD-L1+ phenotype in prostate cancer. OncoImmunology 3:9.
Read now
Read now
Gautier Stoll, David Enot, Bernhard Mlecnik, Jérôme Galon, Laurence Zitvogel & Guido Kroemer. (2014) Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy. OncoImmunology 3:3.
Read now
Read now
Erika Vacchelli, Ilio Vitale, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fučíková, Isabelle Cremer, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:10.
Read now
Read now
Articles from other publishers (21)
Elisa C Toffoli, Amanda A van Vliet, Henk W M Verheul, Hans J van der Vliet, Jurriaan Tuynman, Jan Spanholtz & Tanja D de Gruijl. (2023) Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer 11:12, pages e007554.
Crossref
Crossref
Elisabetta Michielon, Marta López González, Dorian A. Stolk, Joeke G. C. Stolwijk, Sanne Roffel, Taco Waaijman, Sinéad M. Lougheed, Tanja D. de Gruijl & Susan Gibbs. (2023) A Reconstructed Human Melanoma-in-Skin Model to Study Immune Modulatory and Angiogenic Mechanisms Facilitating Initial Melanoma Growth and Invasion. Cancers 15:10, pages 2849.
Crossref
Crossref
Eleonora Sosa Cuevas, Philippe Saas & Caroline Aspord. (2023) Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation. Cancers 15:8, pages 2206.
Crossref
Crossref
Linda Řandová & Ondřej Kodet. (2023) Mechanisms of resistance to melanoma immunotherapy. Onkologie 17:1, pages 51-56.
Crossref
Crossref
Mariana Reis-Sobreiro, Afonso Teixeira da Mota, Carolina Jardim & Karine Serre. (2021) Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages. Cells 10:9, pages 2364.
Crossref
Crossref
Yu Yuan, Abdalla Adam, Chen Zhao & Honglei Chen. (2021) Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy. Cancers 13:4, pages 663.
Crossref
Crossref
Ioanna Milenova, Marta Lopez Gonzalez, Dafne C.A. Quixabeira, Joao Manuel SantosVictor Cervera-Carrascon, Wenliang Dong, Akseli HemminkiVictor W. van Beusechem, Rieneke van de Ven & Tanja D. de Gruijl. (2021) Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma. Human Gene Therapy 32:3-4, pages 178-191.
Crossref
Crossref
Elisabetta Michielon, Marta López González, Judith L. A. Burm, Taco Waaijman, Ekaterina S. Jordanova, Tanja D. de Gruijl & Susan Gibbs. (2020) Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10. Cancer Immunology, Immunotherapy 69:11, pages 2319-2331.
Crossref
Crossref
M López González, R van de Ven, H de Haan, J Eck van der Sluijs, W Dong, V W van Beusechem & T D de Gruijl. (2020) Oncolytic adenovirus ORCA-010 increases the type 1 T cell stimulatory capacity of melanoma-conditioned dendritic cells. Clinical and Experimental Immunology 201:2, pages 145-160.
Crossref
Crossref
S. Di Blasio, G. F. van Wigcheren, A. Becker, A. van Duffelen, M. Gorris, K. Verrijp, I. Stefanini, G. J. Bakker, M. Bloemendal, A. Halilovic, A. Vasaturo, G. Bakdash, S. V. Hato, J. H. W. de Wilt, J. Schalkwijk, I. J. M. de Vries, J. C. Textor, E. H. van den Bogaard, M. Tazzari & C. G. Figdor. (2020) The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture. Nature Communications 11:1.
Crossref
Crossref
Teresa Amaral, Olivia Seeber, Edgar Mersi, Stephanie Sanchez, Ioannis Thomas, Andreas Meiwes, Andrea Forschner, Ulrike Leiter, Thomas Eigentler, Ulrike Keim & Claus Garbe. (2020) Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma. Cancers 12:4, pages 1027.
Crossref
Crossref
Kazuaki Harada, Fumie Ihara, Mariko Takami, Toshiko Kamata, Naoko Mise, Hiroko Yoshizawa, Tomoro Hishiki, Takeshi Saito, Keita Terui, Mitsuyuki Nakata, Shugo Komatsu, Takayuki Ikeuchi, Toshinori Nakayama, Hideo Yoshida & Shinichiro Motohashi. (2019) Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation. Cancer Science 110:3, pages 888-902.
Crossref
Crossref
Tuba N. Gide, James S. Wilmott, Richard A. Scolyer & Georgina V. Long. (2018) Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma. Clinical Cancer Research 24:6, pages 1260-1270.
Crossref
Crossref
Kristian M. Hargadon. (2017) Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma. Frontiers in Immunology 8.
Crossref
Crossref
Diana Llopiz, Marta Ruiz, Stefany Infante, Lorea Villanueva, Leyre Silva, Sandra Hervas-Stubbs, Diego Alignani, Elizabeth Guruceaga, Juan J. Lasarte & Pablo Sarobe. (2016) IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination. Oncotarget 8:2, pages 2659-2671.
Crossref
Crossref
Na LI, Dandan YIN, Hui-Jie ZHANG, Jinmei XU, Fan WEN, Zheng LIU, Yaozhen CHEN, Ning AN, Jiajia XIN, Yazhou WANG, Wen YIN & Xingbin HU. (2017) The Sca1+ mesenchymal stromal subpopulation promotesdendritic cell commitment in the niche. TURKISH JOURNAL OF BIOLOGY 41, pages 58-65.
Crossref
Crossref
A Marijne Heeren, Simone Punt, Maaike CG Bleeker, Katja N Gaarenstroom, Jacobus van der Velden, Gemma G Kenter, Tanja D de Gruijl & Ekaterina S Jordanova. (2016) Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix. Modern Pathology 29:7, pages 753-763.
Crossref
Crossref
Tatiana Zorina & Alexis Styche. 2015. Infection and Cancer: Bi-Directorial Interactions. Infection and Cancer: Bi-Directorial Interactions
295
311
.
DA-EN CHENG, YING-MING TSAI, YA-LING HSU, MING-FENG HOU, EING-MEI TSAI, JAW-YUAN WANG, JUNG-YU KAN & PO-LIN KUO. (2014) Cluster of differentiation 45 activation is crucial in interleukin-10-dependent tumor-associated dendritic cell differentiation. Oncology Letters 8:2, pages 620-626.
Crossref
Crossref
Shasha Song, Pingfan Yuan, Huaxun Wu, Jingyu Chen, Jingjing Fu, Peipei Li, Jingtao Lu & Wei Wei. (2014) Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells. International Immunopharmacology 20:1, pages 117-123.
Crossref
Crossref
Giulia Orsini, Annalisa Legitimo, Alessandra Failli, Paola Ferrari, Andrea Nicolini, Roberto Spisni, Paolo Miccoli & Rita Consolini. (2013) Defective Generation and Maturation of Dendritic Cells from Monocytes in Colorectal Cancer Patients during the Course of Disease. International Journal of Molecular Sciences 14:11, pages 22022-22041.
Crossref
Crossref